Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic Engineering of a Serotonin Overproducing Saccharomyces cerevisiae Strain

  • Planells Cárcel, Andrés
  • Valera García, Elena
  • Quintas, Guillermo
  • Doménech, José Luis
  • Muñiz Calvo, Sara
  • Guillamón, José Manuel
The EU Green Deal prioritises the transformation of the chemical industry to a more environmentally sustainable model. This involves using microorganisms, such as Saccharomyces cerevisiae, to produce molecules more sustainably through biotechnological approaches. In this study, we demonstrate an example of serotonin production using S. cerevisiae as a cell factory, along with its optimisation and upscaling. To achieve this, we introduced two heterologous genes, the combination of tryptophan decarboxylase from Clostridium sporogenes (CsTDC) and tryptamine 5-hydroxylase from Oryza sativa (OsT5H), to complete the serotonin biosynthetic pathway using L-tryptophan (L-TRP) as a precursor. By modifying ARO4 to a feedback-resistant version (ARO4*), the flux of the shikimate pathway was significantly increased and serotonin production was achieved at levels up to 120 mg/L directly from the glucose source. After a medium optimisation, a final concentration of 80 g/L glucose and 300 mg/L of nitrogen resulted in better conditions for increasing serotonin titres. Using this medium in a 1 L bioreactor fermentation resulted in approximately 250 mg/L of serotonin. A targeted metabolomic study of the bioreactor growth medium identified potential bottlenecks in the serotonin-overproducing strain and future targets for increasing its titre. We have constructed a strain of S. cerevisiae that represents the first steps towards feasible industrial production of serotonin using a sustainable and environmentally friendly approach, paving the way for the development of similar biotechnological strategies in the future., This work was funded by MCIN/AEI/10.13039/501100011033, grant number PID2022-142748OB-I00 and TED2021-132386B-I00, and by Generalitat Valenciana, grant number AGROALNEXT/2022/049. APC thank to FPU19/02060 grant funded by “ESF Investing in your future” (MCIN/AEI/10.13039/501100011033). Authors acknowledge the award of the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence (CEX2021-001189-S/ MICIU/AEI / 10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring Proteomic and Metabolomic Interactions in a Yeast Consortium Designed to Enhance Bioactive Compounds in Wine Fermentations

  • Planells Cárcel, Andrés
  • Quintas, Guillermo
  • Pardo, Judit
  • García-Ríos, Estefani
  • Guillamón, José Manuel
There is a new trend in modern oenology to inoculate more than one yeast strain in order to increase microbial diversity and respond to some of the new demands of the wine market. The presence of bioactive molecules in wine is clearly one of these consumer demands, as it can contribute to the bioactivity, quality, and stability of the final products. As many of these bioactive molecules are a consequence of yeast metabolism, our aim in this study was to increase the concentration of tryptophan-derived indole metabolites using a consortium of two Saccharomyces strains, one Saccharomyces cerevisiae (Sc) and one Saccharomyces uvarum (Su), and to understand the molecular and metabolic mechanisms that led to the enhanced biosynthesis of these molecules. The comparison of the proteome of these two strains growing in pure and co-inoculated fermentation, together with a metabolic study of the final wines, has revealed the main strategies of competence in both species. Both proteomic and metabolomic data indicated that the presence of a competitive strain in the same fermentation medium accelerated the growth rate of Sc, upregulated protein translation and ribosome formation, whereas it enhanced the production of bioactive molecules derived from tryptophan in Su, which showed a natural enrichment in metabolites of aromatic amino acid biosynthesis pathway. This study confirmed the idea of combining yeast strains and species as an oenological tool to produce wines of different quality and the need to study the mechanisms of interaction between strains in order to predict the final results., This work was funded by MCIN/AEI/10.13039/501100011033, grant number PID2022-142748OB-I00 and TED2021-132386B-I00. A.P.-C. thank to FPU19/02060 grant funded by “ESF Investing in your future.” E.G.-R. is supported by the Generalitat Valenciana plan GenT grant N°CIDEIG/2022/028., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

IAT4, a New Indolamine N-Acetyltransferase in Saccharomyces cerevisiae Involved in Melatonin Biosynthesis

  • Planells Cárcel, Andrés
  • Sánchez Martí, Sandra
  • Muñiz Calvo, Sara
  • Guillamón, José Manuel
Melatonin synthesis by yeast has been described on several occasions, mainly in a fermentative context. However, the genetic determinants involved in its synthesis remain undefined. Understanding melatonin synthesis in yeast is important because it can provide insights into the broader mechanisms of indolamine production, which has implications for both basic biological research and industrial applications. Although two genes with N-acetyltransferase (NAT) activity (PAA1 and HPA2) have been identified in Saccharomyces cerevisiae, these genes do not seem to be major contributors to the production of melatonin and other indolamines in yeast in vivo. In this study, we identified the uncharacterized gene YDR391C as the gene encoding a protein with NAT activity, herein named IAT4. By comparing different substrates using the purified Iat4, we found that the Km values were 353, 356, and 930 µM towards 5-methoxytryptamine, tryptamine, and serotonin, respectively. The substrate affinity of Iat4 towards serotonin was approximately five times higher than that reported for the previous homolog of the melatonin enzyme arylalkylamine N-acetyltransferase (PAA1), suggesting that IAT4 could play a more significant role in melatonin biosynthesis. This enhanced affinity could lead to more efficient production of N-acetylserotonin, potentially improving yields in biotechnological applications. Finally, we demonstrate the conversion of serotonin into microbially-produced N-acetylserotonin by overexpressing IAT4 in a serotonin-overproducing yeast strain at a titer of 14.5 mg/L. These findings represent the first steps towards the development of yeast strains optimized for the biological production of N-acetylserotonin and related compounds, which might aid in studying the regulatory mechanisms and functions related to melatonin biosynthesis in S. cerevisiae and other yeast species., This study was funded by MCIN/AEI/10.13039/501100011033, grant number PID2022-142748OB-I00 and TED2021-132386B-I00, and by Generalitat Valenciana, grant number AGROALNEXT/2022/049. A.P.C. is thankful for the FPU19/02060 grant funded by “ESF Investing in your future”. Authors acknowledge the award of the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence “Severo Ochoa” (CEX2021-001189-S/MICIU/AEI/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2021-001189-S), Peer reviewed